Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ALLO
ALLO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALLO News
Allogene Showcases CAR T Therapy Potential at AACR Meeting
1d ago
Newsfilter
Allogene Publishes Preclinical Data for ALLO-329 in Autoimmune Diseases
6d ago
Newsfilter
Allogene Therapeutics Prices $175M Public Offering of Common Stock
Apr 15 2026
seekingalpha
Allogene Therapeutics Prices $175 Million Public Offering
Apr 15 2026
NASDAQ.COM
Allogene Therapeutics Prices Public Offering at $2.00 per Share
Apr 15 2026
Yahoo Finance
Amazon Nears Globalstar Acquisition, Stock Soars
Apr 14 2026
seekingalpha
Allogene Therapeutics Proposes $175 Million Public Offering
Apr 14 2026
NASDAQ.COM
Allogene Therapeutics Plans $175M Public Offering of Common Stock
Apr 13 2026
seekingalpha
Stock Price Movements of Various Companies
Apr 13 2026
CNBC
Allogene Therapeutics CAR-T Therapy Shows Promising Phase 2 Trial Results
Apr 13 2026
seekingalpha
Allogene's Cancer Treatment Trial Data Shows Significant Improvement
Apr 13 2026
stocktwits
Cema-Cel Treatment Shows Significant Efficacy in LBCL Trial
Apr 13 2026
Newsfilter
Analysts Predict 180% Upside for Allogene Therapeutics
Apr 12 2026
Yahoo Finance
El Pollo Loco Surges After Strong Q4 Earnings Beat Estimates
Mar 13 2026
Benzinga
Allogene Therapeutics Q4 2025 Earnings Call Insights
Mar 13 2026
seekingalpha
Allogene (ALLO) Q4 2025 Earnings Call Transcript
Mar 13 2026
NASDAQ.COM
Show More News
